ข่าวประชาสัมพันธ์ Prostate Cancer

St. George's University Urges Early Screening to Prevent Prostate Cancer in Men's Health Awareness Month

According to the Department of Medical Services, prostate cancer is the fourth common cancer with an average of 3,700 new cases each year in Thailand. To mark Men's Health Awareness Month, St. George's University (SGU) School of Medicine in Grenada, West Indies, highlights essential steps that Thai men should be aware of to prevent prostate cancer and maintain good health. 1) Get Checked Early Thai men aged over 40, especially those who have family members treated for prostate cancer, should get

MIM Software Inc. ประกาศความร่วมมือกับ Peter MacCallum Cancer Centre เพื่อปรับปรุงการจัดการผู้ป่วย

MIM Software Inc. บริษัทชั้นนำระดับโลกผู้ให้บริการซอฟต์แวร์การถ่ายภาพทางการแพทย์ ประกาศความร่วมมือกับโรงพยาบาล Peter MacCallum Cancer Centre (Peter Mac) ผ่านทางโปรแกรม Prostate Cancer Theranostics and...

MIM Software Inc. Announces Collaboration with Peter MacCallum Cancer Centre to Improve Patient Management

MIM Software Inc., a leading global provider of medical imaging software, announced today a collaboration with Peter MacCallum Cancer Centre (Peter Mac) in support of its Prostate Cancer...

miR Scientific Announces Validation of its Urine Based, Non-Invasive Prostate Cancer Test Published in the Journal of Urology

- Validated Data Reinforces Capability to Molecularly Detect and Characterize Prostate Cancer with Concurrent Sensitivity and Specificity of Over 91% - Data Support...

นพ.พงษ์สันติ์ ลี้สัมพันธ์ (ขวา) รองผู้อำน... ภาพข่าว: โครงการความร่วมมือระหว่าง รพ.รามาธิบดี และรพ.หัวเฉียว — นพ.พงษ์สันติ์ ลี้สัมพันธ์ (ขวา) รองผู้อำนวยการฝ่ายคุณภาพ โรงพยาบาลหัวเฉียว ร่วมถ่ายภาพกับ...

Innovative App Determines Prostate Cancer Risk Level

App for individualized prostate cancer prevention opens up new possibilities The ProstateCheck app promotes early detection of the dangerous disease and helps to prevent unnecessary screenings by extending previous check-up intervals of one year...

23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated in Clinical Trials Using the ExAblate(R) Non-Invasive Prostate Cancer System

Initial Results are Encouraging, Spurring Hope for a Treatment Option with a Lower Rate of Complications InSightec Ltd., the global leader in MR...

InSightec Treats First Prostate Cancer Patients in Clinical Trials

- ExAblate(R) MR Guided Focused Ultrasound System is Being Used for the First Time for Non-invasive Treatment of Prostate Cancer - Seven Patients With Prostate Confined Low Risk Cancer Treated in Clinical Trials InSightec Ltd., the...

Committee for Medicinal Products for Human Use (CHMP) Recommends Granting Marketing Authorisation for FIRMAGON(R) (degarelix) for Treatment of Prostate Cancer

- New Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist Demonstrates Rapid, Long-Term Suppression of Testosterone Ferring...

New Research(1) Calls for Reclassification of Zoladex as Curative

Findings Challenge Historical Assumptions & Current Guidelines for Treating Non-Metastatic Poor Prognosis Prostate Cancer With Adjuvant LHRHas New research presented today at the 28th Congress of the Societe Internationale d'Urologie ...